These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 31564416)
1. Altered mitochondrial DNA methylation and mitochondrial DNA copy number in an APP/PS1 transgenic mouse model of Alzheimer disease. Xu Y; Xu L; Han M; Liu X; Li F; Zhou X; Wang Y; Bi J Biochem Biophys Res Commun; 2019 Nov; 520(1):41-46. PubMed ID: 31564416 [TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of Mitochondrial Cytochrome b and Cytochrome c Oxidase II Genes with Decreased Mitochondrial DNA Copy Numbers in the APP/PS1 Transgenic Mouse Model of Alzheimer's Disease. Xu Y; Cheng L; Sun J; Li F; Liu X; Wei Y; Han M; Zhu Z; Bi J; Lai C; Wang Y Neurochem Res; 2021 Mar; 46(3):564-572. PubMed ID: 33580369 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia-up-regulated mitochondrial movement regulator does not contribute to the APP/PS1 double transgenic mouse model of Alzheimer's disease. Zou Y; Li Y; Yu W; Du Y; Shi R; Zhang M; Duan J; Deng Y; Tu Q; Dai R; Lü Y Dement Geriatr Cogn Disord; 2013; 36(3-4):137-45. PubMed ID: 23900018 [TBL] [Abstract][Full Text] [Related]
4. Folic acid attenuates the effects of amyloid β oligomers on DNA methylation in neuronal cells. Liu H; Li W; Zhao S; Zhang X; Zhang M; Xiao Y; Wilson JX; Huang G Eur J Nutr; 2016 Aug; 55(5):1849-62. PubMed ID: 26224648 [TBL] [Abstract][Full Text] [Related]
5. Folic acid administration inhibits amyloid β-peptide accumulation in APP/PS1 transgenic mice. Li W; Liu H; Yu M; Zhang X; Zhang M; Wilson JX; Huang G J Nutr Biochem; 2015 Aug; 26(8):883-91. PubMed ID: 25959374 [TBL] [Abstract][Full Text] [Related]
6. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice. Liu HL; Zhao G; Zhang H; Shi LD Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591 [TBL] [Abstract][Full Text] [Related]
7. [Reproduction,genotype identification and evaluation of APP/PS1 transgenic mice]. Tan L; Li HQ; Li YB; Liu W; Pang W; Jiang YG Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Feb; 34(2):111-114. PubMed ID: 29926672 [TBL] [Abstract][Full Text] [Related]
8. Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)]. Esteras N; Bartolomé F; Alquézar C; Antequera D; Muñoz Ú; Carro E; Martín-Requero Á Eur J Neurosci; 2012 Sep; 36(5):2609-18. PubMed ID: 22702220 [TBL] [Abstract][Full Text] [Related]
9. Cerebral microemboli increase β-amyloid protein deposition, MMP-9, and GFAP expression in the Alzheimer`s model of APP/PS1 double transgenic mice. Ning M; Wu Y; Ni X; Zhao Y; Ling R Curr Neurovasc Res; 2014; 11(3):190-201. PubMed ID: 24962158 [TBL] [Abstract][Full Text] [Related]
10. Altered Mitochondrial DNA Methylation Pattern in Alzheimer Disease-Related Pathology and in Parkinson Disease. Blanch M; Mosquera JL; Ansoleaga B; Ferrer I; Barrachina M Am J Pathol; 2016 Feb; 186(2):385-97. PubMed ID: 26776077 [TBL] [Abstract][Full Text] [Related]
11. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline. Macklin L; Griffith CM; Cai Y; Rose GM; Yan XX; Patrylo PR Exp Gerontol; 2017 Feb; 88():9-18. PubMed ID: 28025127 [TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis of DNA methylation in an APP/PS1 mouse model of Alzheimer's disease. Cong L; Jia J; Qin W; Ren Y; Sun Y Acta Neurol Belg; 2014 Sep; 114(3):195-206. PubMed ID: 24347181 [TBL] [Abstract][Full Text] [Related]
14. β-asarone improves learning and memory and reduces Acetyl Cholinesterase and Beta-amyloid 42 levels in APP/PS1 transgenic mice by regulating Beclin-1-dependent autophagy. Deng M; Huang L; Ning B; Wang N; Zhang Q; Zhu C; Fang Y Brain Res; 2016 Dec; 1652():188-194. PubMed ID: 27737765 [TBL] [Abstract][Full Text] [Related]
15. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease. Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271 [TBL] [Abstract][Full Text] [Related]
16. APP/PS1 transgenic mice treated with aluminum: an update of Alzheimer's disease model. Zhang QL; Jia L; Jiao X; Guo WL; Ji JW; Yang HL; Niu Q Int J Immunopathol Pharmacol; 2012; 25(1):49-58. PubMed ID: 22507317 [TBL] [Abstract][Full Text] [Related]
17. Proteomic Profiles of the Early Mitochondrial Changes in APP/PS1 and ApoE4 Transgenic Mice Models of Alzheimer's Disease. He K; Nie L; Zhou Q; Rahman SU; Liu J; Yang X; Li S J Proteome Res; 2019 Jun; 18(6):2632-2642. PubMed ID: 31055927 [TBL] [Abstract][Full Text] [Related]
18. The hypothalamus as the primary brain region of metabolic abnormalities in APP/PS1 transgenic mouse model of Alzheimer's disease. Zheng H; Zhou Q; Du Y; Li C; Xu P; Lin L; Xiao J; Gao H Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):263-273. PubMed ID: 29107091 [TBL] [Abstract][Full Text] [Related]
19. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease. Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117 [TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Sirt3 Expression is Decreased in APP/PS1 Double Transgenic Mouse Model of Alzheimer's Disease. Yang W; Zou Y; Zhang M; Zhao N; Tian Q; Gu M; Liu W; Shi R; Lü Y; Yu W Neurochem Res; 2015 Aug; 40(8):1576-82. PubMed ID: 26045440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]